305 related articles for article (PubMed ID: 776390)
1. Perspectives on research in gynecologic oncology.
DeVita VT; Wasserman TH; Young RC; Carter SK
Cancer; 1976 Jul; 38(1 SUPPL):509-25. PubMed ID: 776390
[TBL] [Abstract][Full Text] [Related]
2. Combined modality therapy of gynecologic cancer.
Brady LW
Cancer; 1975 Jan; 35(1):76-83. PubMed ID: 1089040
[TBL] [Abstract][Full Text] [Related]
3. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
[TBL] [Abstract][Full Text] [Related]
4. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
7. Pathologic characteristics, type of treatment and follow up of patients with uterine cervical carcinoma referred to the Radiation Oncology Department, Cancer Institute, Imam Khomeini Hospital,Tehran, Iran, 1995-2001.
Farnaz AH; Ebrahim E; Bita K
Asian Pac J Cancer Prev; 2008; 9(1):86-8. PubMed ID: 18439082
[TBL] [Abstract][Full Text] [Related]
8. Treatment of advanced and recurrent gynecologic cancer.
Brady LW; Markoe AM; DeEulis T; Lewis GC
Cancer; 1987 Oct; 60(8 Suppl):2081-93. PubMed ID: 3308068
[TBL] [Abstract][Full Text] [Related]
9. Gynecologic malignancies.
Schilder RJ; Scher RM; Young RC
Cancer Chemother Biol Response Modif; 1993; 14():530-56. PubMed ID: 8312118
[TBL] [Abstract][Full Text] [Related]
10. Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.
Mahmoud O; Hathout L; Shaaban SG; Elshaikh MA; Beriwal S; Small W
Gynecol Oncol; 2016 Dec; 143(3):539-544. PubMed ID: 27769525
[TBL] [Abstract][Full Text] [Related]
11. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
12. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for advanced or recurrent gynecologic cancer.
Thigpen T; Vance R; Lambuth B; Balducci L; Khansur T; Blessing J; McGehee R
Cancer; 1987 Oct; 60(8 Suppl):2104-16. PubMed ID: 3308070
[TBL] [Abstract][Full Text] [Related]
14. Epithelial carcinoma of the ovary: current strategies.
Katz ME; Schwartz PE; Kapp DS; Luikart S
Ann Intern Med; 1981 Jul; 95(1):98-111. PubMed ID: 6787963
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
[TBL] [Abstract][Full Text] [Related]
16. Combined modality therapy for gynecologic cancer.
Ackerman I; Thomas GM
Curr Opin Oncol; 1995 Sep; 7(5):466-72. PubMed ID: 8541393
[TBL] [Abstract][Full Text] [Related]
17. Issues in gynecologic radiation oncology.
Randall ME; Evans L
Curr Opin Oncol; 1991 Oct; 3(5):920-9. PubMed ID: 1751583
[TBL] [Abstract][Full Text] [Related]
18. A retrospective review of patients with stage IB2 cervical cancer treated with radical radiation versus radical surgery as a primary modality.
Alleyne-Mike K; van Wijk L; Hunter A
Int J Gynecol Cancer; 2013 Sep; 23(7):1287-94. PubMed ID: 23863456
[TBL] [Abstract][Full Text] [Related]
19. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
20. [Recurrent cervical cancer--therapeutic options].
Zółciak-Siwińska A; Jońska-Gmyrek J; Socha J
Ginekol Pol; 2012 Jul; 83(7):527-31. PubMed ID: 22880478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
